HPV 16- and/or HPV 18-Infected Women With Normal Cytology, ASCUS, or LSIL

Clinical trial pipeline · Data from ClinicalTrials.gov

See which HPV 16- and/or HPV 18-Infected Women With Normal Cytology, ASCUS, or LSIL trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (2 shown)

CompletedPhase 2

NCT01957878

Phase II Study of HPV Therapeutic Vaccine in HPV Infected Women With Normal Cytology or ASCUS/LSIL

Human Papillomavirus (HPV) 16 and HPV 18 (the two virus genotypes targeted by the ProCervix vaccine) are the most common HPV genotypes associated with at least…

Belgium, Finland239 participantsStarted 2013-12

Treatment: ProCervix, Placebo

TerminatedPhase 1

NCT02689726

Safety, Tolerability, and Immunogenicity of GTL001 Vaccine Adjuvanted With Imiquimod Cream in HPV 16- and/or HPV 18-Infe…

A Phase 1, Open-Label Study to Evaluate the Safety, Tolerability, and Immunogenicity of GTL001 Vaccine Adjuvanted With Imiquimod Cream in HPV 16- and/or HPV 18-…

United States13 participantsStarted 2015-08

Treatment: GTL001+, Aldara